In addition, screening or designing novel small molecular inhibitors utilizing artificial intelligence (AI) techniques and developing other targeting strategies such as targeted protein degradation may open new avenues for targeting METTL3 in cancer therapy. The gene discussed is METTL3; the disease is cancer.